CA2452033A1 - Graft prosthesis devices containing renal capsule collagen - Google Patents

Graft prosthesis devices containing renal capsule collagen Download PDF

Info

Publication number
CA2452033A1
CA2452033A1 CA002452033A CA2452033A CA2452033A1 CA 2452033 A1 CA2452033 A1 CA 2452033A1 CA 002452033 A CA002452033 A CA 002452033A CA 2452033 A CA2452033 A CA 2452033A CA 2452033 A1 CA2452033 A1 CA 2452033A1
Authority
CA
Canada
Prior art keywords
renal capsule
tissue
collagen
graft prosthesis
tissue graft
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA002452033A
Other languages
French (fr)
Other versions
CA2452033C (en
Inventor
Umesh H. Patel
Michael C. Hiles
Jason P. Hodde
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cook Biotech Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2452033A1 publication Critical patent/CA2452033A1/en
Application granted granted Critical
Publication of CA2452033C publication Critical patent/CA2452033C/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel
    • A61L27/3633—Extracellular matrix [ECM]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0009—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form containing macromolecular materials
    • A61L26/0028—Polypeptides; Proteins; Degradation products thereof
    • A61L26/0033—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L26/00—Chemical aspects of, or use of materials for, wound dressings or bandages in liquid, gel or powder form
    • A61L26/0057—Ingredients of undetermined constitution or reaction products thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/14—Macromolecular materials
    • A61L27/22—Polypeptides or derivatives thereof, e.g. degradation products
    • A61L27/24—Collagen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • A61L27/3604—Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix characterised by the human or animal origin of the biological material, e.g. hair, fascia, fish scales, silk, shellac, pericardium, pleura, renal tissue, amniotic membrane, parenchymal tissue, fetal tissue, muscle tissue, fat tissue, enamel

Abstract

The invention provides tissue graft compositions comprising collagen-based extracellular matrices derived from renal capsules of warm-blooded vertebrates. The invention further provides a process of harvesting and purifying a renal capsule to provide an extracellular matrix material having beneficial use as a tissue graft and/or cell growth material.

Claims (31)

1. A tissue graft prosthesis comprising renal capsule collagen.
2. The tissue graft prosthesis of claim 1 wherein said renal capsule collagen is from a warm blooded vertebrate.
3. The tissue graft prosthesis of claim 2 comprising a sheet of renal capsule collagen.
4. The tissue graft prosthesis of claim 3 wherein said sheet of renal capsule collagen exhibits a tensile strength of at least about 4 MPa.
5. The tissue graft prosthesis of claim 3 wherein said sheet of renal capsule collagen has an endotoxin level no greater than 20 endotoxin units per gram.
6. The tissue graft prosthesis of claim 5 wherein said sheet of renal capsule collagen has a bioburden level of less than 2 colony forming units per gram.
7. The tissue graft prosthesis of claim 1 wherein said graft prosthesis is a powder.
8. The tissue graft prosthesis of claim 1 wherein said graft prosthesis is a tube.
9. The tissue graft prosthesis of claim 1 wherein said graft prosthesis is an essentially planar sheet.
10. An article of manufacture comprising renal capsule collagen and sterile packaging containing the renal capsule collagen.
11. The article of claim 10 wherein said renal capsule collagen is dried.
12. The articles of claim 10 wherein said renal capsule collagen is in hydrated form.
13. The article of claim 10 wherein said renal capsule collagen is in sheet form.
14. The article of claim 10 wherein said renal capsule collagen is in powder form.
15. The article of claim 10 wherein said renal capsule collagen is in tubular form.
16. The article of claim 10 wherein said renal capsule collagen is in fluidized form.
17. A method for preparing an extracellular matrix composition, comprising:
decellularizing renal capsule tissue to form the extracellular matrix composition.
18. The method of claim 17 wherein said renal capsule tissue is from a warm-blooded vertebrate.
19. The method of claim 18 wherein said warm-blooded vertebrate is selected from a group consisting of porcine, bovine and ovine.
20. The method of claim 18 wherein said warm-blooded vertebrate is a pig.
21. The method of claim 17 wherein said decellularizing comprises exposing said renal capsule tissue to a decellularization agent.
22. The method of claim 21 wherein said agent is an oxidizing agent.
23. The method of claim 21 wherein said agent is a peroxy compound.
24. The method of claim 23 wherein said peroxy compound is peracetic acid.
25. The method of claim 17 wherein said tissue graft composition comprises a renal capsule extracellular matrix structure having a tensile strength of at least about 4 MPa.
26. The method of claim 17 further comprising forming said renal capsule tissue into a powder.
27. The method of claim 17 further comprising fluidizing said renal capsule tissue by enzyme digestion.
28. The method of claim 21 wherein said agent is a hypertonic salt solution.
29. A method of tissue grafting, comprising grafting a mammal with renal capsule collagen.
30. The method of tissue grafting of claim 29 wherein said renal capsule collagen is from an animal xenogenic to said mammal.
31. The method of tissue grafting of claim 30 wherein said renal capsule is porcine renal capsule.
CA2452033A 2001-06-28 2002-06-28 Graft prosthesis devices containing renal capsule collagen Expired - Lifetime CA2452033C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US30167101P 2001-06-28 2001-06-28
US60/301,671 2001-06-28
PCT/US2002/020499 WO2003002165A1 (en) 2001-06-28 2002-06-28 Graft prosthesis devices containing renal capsule collagen

Publications (2)

Publication Number Publication Date
CA2452033A1 true CA2452033A1 (en) 2003-01-09
CA2452033C CA2452033C (en) 2011-11-08

Family

ID=23164353

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2452033A Expired - Lifetime CA2452033C (en) 2001-06-28 2002-06-28 Graft prosthesis devices containing renal capsule collagen

Country Status (6)

Country Link
US (2) US7087089B2 (en)
EP (1) EP1404388B1 (en)
JP (1) JP4426285B2 (en)
AU (1) AU2002320189B2 (en)
CA (1) CA2452033C (en)
WO (1) WO2003002165A1 (en)

Families Citing this family (137)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6485723B1 (en) * 1995-02-10 2002-11-26 Purdue Research Foundation Enhanced submucosal tissue graft constructs
ES2208974T3 (en) * 1996-08-23 2004-06-16 Cook Biotech, Inc. PROTESIS OF GRAFT, MATERIALS AND METHODS.
US6638312B2 (en) * 2000-08-04 2003-10-28 Depuy Orthopaedics, Inc. Reinforced small intestinal submucosa (SIS)
US8366787B2 (en) * 2000-08-04 2013-02-05 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorbable scaffolds
US8038708B2 (en) 2001-02-05 2011-10-18 Cook Medical Technologies Llc Implantable device with remodelable material and covering material
AU2002320189B2 (en) * 2001-06-28 2007-04-26 Cook Biotech Incorporated Graft prosthesis devices containing renal capsule collagen
US7819918B2 (en) * 2001-07-16 2010-10-26 Depuy Products, Inc. Implantable tissue repair device
WO2003007787A2 (en) * 2001-07-16 2003-01-30 Depuy Products, Inc. Cartilage repair and regeneration device and method
US8025896B2 (en) * 2001-07-16 2011-09-27 Depuy Products, Inc. Porous extracellular matrix scaffold and method
AU2002354911B2 (en) * 2001-07-16 2007-08-30 Depuy Products, Inc. Meniscus regeneration device and method
AU2002322567B2 (en) * 2001-07-16 2007-09-06 Depuy Products, Inc. Devices form naturally occurring biologically derived
WO2003007789A2 (en) * 2001-07-16 2003-01-30 Depuy Products, Inc. Porous extracellular matrix scaffold and method
EP1416874A4 (en) 2001-07-16 2007-04-18 Depuy Products Inc Hybrid biologic/synthetic porous extracellular matrix scaffolds
AU2002354913B2 (en) * 2001-07-16 2008-07-17 Depuy Products, Inc. Unitary surgical device and method
US7377938B2 (en) * 2001-07-19 2008-05-27 The Cleveland Clinic Foundation Prosthetic cardiac value and method for making same
DE60225824T2 (en) * 2001-10-26 2009-04-16 Cook Biotech, Inc., West Lafayette MEDICAL IMPLANT WITH NETWORK STRUCTURE
US8105580B2 (en) 2001-12-07 2012-01-31 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to promote wound healing
EP1921133B1 (en) 2001-12-07 2015-05-20 Cytori Therapeutics, Inc. System for processing lipoaspirate cells
US7651684B2 (en) * 2001-12-07 2010-01-26 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in augmenting autologous fat transfer
US20060204556A1 (en) * 2001-12-07 2006-09-14 Cytori Therapeutics, Inc. Cell-loaded prostheses for regenerative intraluminal applications
US20050008626A1 (en) * 2001-12-07 2005-01-13 Fraser John K. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US7585670B2 (en) 2001-12-07 2009-09-08 Cytori Therapeutics, Inc. Automated methods for isolating and using clinically safe adipose derived regenerative cells
US20050095228A1 (en) * 2001-12-07 2005-05-05 Fraser John K. Methods of using regenerative cells in the treatment of peripheral vascular disease and related disorders
US7514075B2 (en) * 2001-12-07 2009-04-07 Cytori Therapeutics, Inc. Systems and methods for separating and concentrating adipose derived stem cells from tissue
US8404229B2 (en) * 2001-12-07 2013-03-26 Cytori Therapeutics, Inc. Methods of using adipose derived stem cells to treat acute tubular necrosis
US20050048036A1 (en) * 2001-12-07 2005-03-03 Hedrick Marc H. Methods of using regenerative cells in the treatment of inherited and acquired disorders of the bone, bone marrow, liver, and other tissues
US7595043B2 (en) * 2001-12-07 2009-09-29 Cytori Therapeutics, Inc. Method for processing and using adipose-derived stem cells
US9597395B2 (en) 2001-12-07 2017-03-21 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of cardiovascular conditions
US7771716B2 (en) * 2001-12-07 2010-08-10 Cytori Therapeutics, Inc. Methods of using regenerative cells in the treatment of musculoskeletal disorders
CN1713861A (en) * 2002-05-02 2005-12-28 普渡研究基金会 Vascularization enhanced graft constructs
NZ536564A (en) 2002-05-02 2008-05-30 Purdue Research Foundation Vascularization enhanced graft constructs which comprise a matrix composition consisting of liver basement membrane
CN1684589A (en) * 2002-05-02 2005-10-19 普渡研究基金会 Vascularization enhanced graft constructs
US8313760B2 (en) 2002-05-24 2012-11-20 Angiotech International Ag Compositions and methods for coating medical implants
EP1509256B1 (en) 2002-05-24 2009-07-22 Angiotech International Ag Compositions and methods for coating medical implants
US20040166169A1 (en) * 2002-07-15 2004-08-26 Prasanna Malaviya Porous extracellular matrix scaffold and method
WO2004082528A2 (en) 2003-03-17 2004-09-30 Cook Incorporated Vascular valve with removable support component
US7871434B2 (en) 2003-04-01 2011-01-18 Cook Incorporated Percutaneously deployed vascular valves
US7326571B2 (en) * 2003-07-17 2008-02-05 Boston Scientific Scimed, Inc. Decellularized bone marrow extracellular matrix
US20050013870A1 (en) * 2003-07-17 2005-01-20 Toby Freyman Decellularized extracellular matrix of conditioned body tissues and uses thereof
GB2424586B (en) 2003-08-25 2008-05-28 Cook Biotech Inc Graft materials containing bioactive substances, and methods for their manufacture
US8043614B2 (en) 2004-03-09 2011-10-25 Ahlfors Jan-Eric W Autogenic living scaffolds and living tissue matrices: methods and uses thereof
AU2004270239C1 (en) 2003-09-04 2011-07-07 Cook Biotech Incorporated Extracellular matrix composite materials, and manufacture and use thereof
US7645229B2 (en) 2003-09-26 2010-01-12 Armstrong David N Instrument and method for endoscopic visualization and treatment of anorectal fistula
WO2005032473A2 (en) * 2003-10-02 2005-04-14 Depuy Spine, Inc. Chemical treatment for removing cellular and nuclear material from naturally occurring extracellular matrix-based biomaterials
WO2005063314A1 (en) * 2003-12-26 2005-07-14 Cardio Incorporated Decellularized tissue and method of preparing the same
CN1909840B (en) 2004-01-21 2012-03-21 库克公司 Implantable graft to close a fistula
US20050283256A1 (en) * 2004-02-09 2005-12-22 Codman & Shurtleff, Inc. Collagen device and method of preparing the same
WO2005077433A1 (en) 2004-02-09 2005-08-25 Cook Biotech Incorporated Stent graft devices having collagen coating
WO2005096989A1 (en) * 2004-03-31 2005-10-20 Cook Incorporated Graft material and stent graft comprising extra collagen matrix and method of preparation
US7648676B2 (en) * 2004-04-20 2010-01-19 Rti Biologics, Inc. Process and apparatus for treating implants comprising soft tissue
US7569233B2 (en) * 2004-05-04 2009-08-04 Depuy Products, Inc. Hybrid biologic-synthetic bioabsorbable scaffolds
US20050249772A1 (en) * 2004-05-04 2005-11-10 Prasanna Malaviya Hybrid biologic-synthetic bioabsorbable scaffolds
JP4928449B2 (en) * 2004-07-02 2012-05-09 クック・インコーポレイテッド Endoluminal prosthesis
US7513866B2 (en) * 2004-10-29 2009-04-07 Depuy Products, Inc. Intestine processing device and associated method
US7905826B2 (en) 2004-11-03 2011-03-15 Cook Incorporated Methods for modifying vascular vessel walls
WO2006062976A2 (en) 2004-12-07 2006-06-15 Cook Incorporated Methods for modifying vascular vessel walls
US7354627B2 (en) * 2004-12-22 2008-04-08 Depuy Products, Inc. Method for organizing the assembly of collagen fibers and compositions formed therefrom
WO2006069349A2 (en) * 2004-12-22 2006-06-29 Cytori Therapeutics, Inc. Cell-loaded prostheses for regenerative intraluminal applications
BRPI0519298A2 (en) * 2005-01-05 2009-01-06 Cleveland Clinic Foundation Method of preparing a biological tissue fixed
EP1844434A4 (en) * 2005-01-10 2013-11-13 Cytori Therapeutics Inc Devices and methods for monitoring, managing, and servicing medical devices
US20060206139A1 (en) * 2005-01-19 2006-09-14 Tekulve Kurt J Vascular occlusion device
EP1856246B1 (en) 2005-03-07 2015-07-15 Technion Research & Development Foundation Limited Natural tissue-derived decellularized matrix and methods of generating and using same
US9138445B2 (en) 2005-03-09 2015-09-22 Cook Biotech Incorporated Medical graft materials with adherent extracellular matrix fibrous mass
US7723108B2 (en) * 2005-03-16 2010-05-25 Musculoskeletal Transplant Foundation Soft tissue processing
US20100112543A1 (en) * 2005-03-16 2010-05-06 Manh-Dan Ngo Processing soft tissue, methods and compositions related thereto
EP1863545B1 (en) 2005-03-19 2015-11-18 Cook Biotech, Inc. Prosthetic implants including ECM composite material
US8475512B2 (en) * 2005-05-17 2013-07-02 Cook Medical Technologies Llc Prosthetic valve devices and methods of making and using such devices
JP2008543504A (en) 2005-06-21 2008-12-04 クック・インコーポレイテッド Implantable graft to close the fistula
WO2007016251A2 (en) * 2005-07-28 2007-02-08 Cook Incorporated Implantable thromboresistant valve
US20070038295A1 (en) * 2005-08-12 2007-02-15 Cook Incorporated Artificial valve prosthesis having a ring frame
US7429241B2 (en) * 2005-09-29 2008-09-30 Codman & Shurtleff, Inc. Dural graft and method of preparing the same
US7503928B2 (en) 2005-10-21 2009-03-17 Cook Biotech Incorporated Artificial valve with center leaflet attachment
US8802113B2 (en) * 2005-10-27 2014-08-12 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US8778362B2 (en) 2005-10-27 2014-07-15 University Of Notre Dame Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof
US8778360B2 (en) * 2005-10-27 2014-07-15 University Of Notre Dame Extracellular matrix cancer vaccine adjuvant
US9308252B2 (en) * 2005-10-27 2016-04-12 Cook Biotech, Inc. Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins
US20070178137A1 (en) * 2006-02-01 2007-08-02 Toby Freyman Local control of inflammation
US7829108B2 (en) * 2006-04-21 2010-11-09 Wake Forest University Health Sciences Structurally modified acellular tissue engineering scaffolds and methods of production
US8092517B2 (en) * 2006-05-25 2012-01-10 Deep Vein Medical, Inc. Device for regulating blood flow
US7811316B2 (en) 2006-05-25 2010-10-12 Deep Vein Medical, Inc. Device for regulating blood flow
WO2007139551A1 (en) * 2006-05-30 2007-12-06 Cytori Therapeutics, Inc. Systems and methods for manipulation of regenerative cells from adipose tissue
EP2020958B1 (en) 2006-05-30 2012-05-30 Cook Medical Technologies LLC Artificial valve prosthesis
WO2008013863A2 (en) * 2006-07-26 2008-01-31 Cytori Therapeutics, Inc. Generation of adipose tissue and adipocytes
CA2667214C (en) 2006-10-23 2015-12-01 Cook Biotech Incorporated Processed ecm materials with enhanced component profiles
GB0622846D0 (en) * 2006-11-16 2006-12-27 Univ Leeds Preparation of tissue for meniscal implantation
EP2094325B1 (en) * 2006-11-16 2011-08-31 The University Of Leeds Preparation of tissue for meniscal implantation
US7871440B2 (en) * 2006-12-11 2011-01-18 Depuy Products, Inc. Unitary surgical device and method
US8343536B2 (en) 2007-01-25 2013-01-01 Cook Biotech Incorporated Biofilm-inhibiting medical products
WO2008101083A2 (en) 2007-02-15 2008-08-21 Cook Incorporated Artificial valve prostheses with a free leaflet portion
US9636438B2 (en) 2007-03-07 2017-05-02 Coloplast A/S Fistula plug comprising ECM
CA2679295A1 (en) * 2007-03-07 2008-09-12 Coloplast A/S Mesh comprising ecm
US9283302B2 (en) 2011-12-16 2016-03-15 Cormatrix Cardiovascular, Inc. Extracellular matrix encasement structures and methods
JP2010528613A (en) 2007-05-29 2010-08-26 クリストファー ビー． リード， Methods for producing pluripotent cell populations and uses thereof
US10500309B2 (en) 2007-10-05 2019-12-10 Cook Biotech Incorporated Absorbable adhesives and their formulation for use in medical applications
US8057532B2 (en) 2007-11-28 2011-11-15 Cook Medical Technologies Llc Implantable frame and valve design
US8679176B2 (en) 2007-12-18 2014-03-25 Cormatrix Cardiovascular, Inc Prosthetic tissue valve
US8257434B2 (en) 2007-12-18 2012-09-04 Cormatrix Cardiovascular, Inc. Prosthetic tissue valve
US8211165B1 (en) 2008-01-08 2012-07-03 Cook Medical Technologies Llc Implantable device for placement in a vessel having a variable size
US9283266B2 (en) * 2008-02-28 2016-03-15 University Of Notre Dame Metastasis inhibition preparations and methods
EP2293745A1 (en) 2008-04-18 2011-03-16 Cook Incorporated Branched vessel prosthesis
AU2009201541B2 (en) * 2008-04-23 2014-12-04 Integra Lifesciences Corporation Flowable collagen material for dural closure
CA2728553C (en) 2008-07-01 2016-08-16 Cook Biotech Incorporated Isolated extracellular matrix material including subserous fascia
WO2010021993A1 (en) 2008-08-19 2010-02-25 Cytori Therapeutics, Inc. Methods of using adipose tissue-derived cells in the treatment of the lymphatic system and malignant disease
CA2752899A1 (en) * 2009-02-18 2010-08-26 Cormatrix Cardiovascular, Inc. Compositions and methods for preventing cardiac arrhythmia
US8906362B2 (en) 2009-03-23 2014-12-09 Wake Forest University Health Sciences Tissue engineered meniscus scaffolds and methods of use
AU2010242780B2 (en) * 2009-05-01 2016-04-21 Puregraft Llc Systems, methods and compositions for optimizing tissue and cell enriched grafts
WO2011031827A2 (en) 2009-09-09 2011-03-17 Cook Biotech Incorporated Manufacture of extracellular matrix products using supercritical or near supercritical fluids
US9211123B2 (en) * 2009-12-31 2015-12-15 Cook Medical Technologies Llc Intraluminal occlusion devices and methods of blocking the entry of fluid into bodily passages
PL2588027T3 (en) * 2010-07-02 2017-09-29 The University Of North Carolina At Chapel Hill Biomatrix scaffolds for industrial scale dispersal
AU2012262549B2 (en) 2011-05-27 2016-02-11 Cormatrix Cardiovascular, Inc. Extracellular matrix material valve conduit and methods of making thereof
US8915941B2 (en) 2011-06-14 2014-12-23 Cook Medical Technologies Llc Fistula closure devices and methods
ES2705823T3 (en) * 2012-01-24 2019-03-26 Lifecell Corp Matrices of elongated tissues
US10940167B2 (en) 2012-02-10 2021-03-09 Cvdevices, Llc Methods and uses of biological tissues for various stent and other medical applications
EP2892541B1 (en) 2012-09-04 2021-04-21 Technion Research & Development Foundation Limited Use of decellularized extracellular matrix for encapsulating cells
US9498559B2 (en) 2012-10-08 2016-11-22 Cormatrix Cardiovascular, Inc. Reinforced vascular protheses
US9757106B2 (en) 2012-12-03 2017-09-12 Cook Medical Technologies Llc Degradable expanding closure plug
AU2014214700B2 (en) 2013-02-11 2018-01-18 Cook Medical Technologies Llc Expandable support frame and medical device
AU2014227561C1 (en) 2013-03-15 2017-12-14 Cook Biotech Incorporated ECM implant compositions and methods
US10029030B2 (en) * 2013-03-15 2018-07-24 Mimedx Group, Inc. Molded placental tissue compositions and methods of making and using the same
WO2015031809A1 (en) * 2013-09-02 2015-03-05 Muffin Incorporated Cell-seeded compositions and methods useful for treating bone regions
US9878071B2 (en) 2013-10-16 2018-01-30 Purdue Research Foundation Collagen compositions and methods of use
JP6524597B2 (en) 2013-11-04 2019-06-05 ライフセル コーポレーションＬｉｆｅＣｅｌｌ Ｃｏｒｐｏｒａｔｉｏｎ Method of removing alpha-galactose
US9801910B2 (en) 2014-03-17 2017-10-31 Ethicon, Inc. Decellularized pleural matrix
EP3229732B1 (en) * 2014-12-10 2021-04-28 Cormatrix Cardiovascular, Inc. Reinforced vascular prostheses
CN107405425B (en) 2014-12-22 2021-03-16 阿罗阿生物外科有限公司 Laminated tissue graft product
US9238090B1 (en) 2014-12-24 2016-01-19 Fettech, Llc Tissue-based compositions
US11919941B2 (en) 2015-04-21 2024-03-05 Purdue Research Foundation Cell-collagen-silica composites and methods of making and using the same
US10195024B2 (en) 2015-10-07 2019-02-05 Boston Scientific Scimed, Inc. Porcine small intestine submucosa leaflet material
US10173027B2 (en) 2015-10-07 2019-01-08 Cook Medical Technologies Llc Methods, medical devices and kits for modifying the luminal profile of a body vessel
US10405975B2 (en) 2015-10-07 2019-09-10 Boston Scientific Scimed, Inc. Cultured cell leaflet material
US10231830B2 (en) * 2015-11-10 2019-03-19 Boston Scientific Scimed, Inc. Kidney capsule leaflet material
CA3055551A1 (en) 2017-03-06 2018-09-13 Tei Biosciences, Inc. Perforated tissue graft
CA3061428A1 (en) 2017-04-25 2018-11-01 Purdue Research Foundation 3-dimensional (3d) tissue-engineered muscle for tissue restoration
WO2019104163A1 (en) * 2017-11-21 2019-05-31 The University Of Akron Amino acid-based poly(ester urea) polymer mesh for hernia and other soft tissue applications
WO2020092456A2 (en) * 2018-11-02 2020-05-07 Aziyo Med, Llc Extracellular matrix pouch structure and uses thereof
US20220023489A1 (en) 2020-07-27 2022-01-27 Cook Biotech Incorporated Adhesive for surgical staple line reinforcement
US11826490B1 (en) 2020-12-29 2023-11-28 Acell, Inc. Extracellular matrix sheet devices with improved mechanical properties and method of making

Family Cites Families (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2127903A (en) 1936-05-05 1938-08-23 Davis & Geck Inc Tube for surgical purposes and method of preparing and using the same
US4502159A (en) * 1982-08-12 1985-03-05 Shiley Incorporated Tubular prostheses prepared from pericardial tissue
US4801299A (en) * 1983-06-10 1989-01-31 University Patents, Inc. Body implants of extracellular matrix and means and methods of making and using such implants
US4829000A (en) 1985-08-30 1989-05-09 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Reconstituted basement membrane complex with biological activity
US4956178A (en) 1988-07-11 1990-09-11 Purdue Research Foundation Tissue graft composition
US4902508A (en) 1988-07-11 1990-02-20 Purdue Research Foundation Tissue graft composition
US5521087A (en) * 1989-05-10 1996-05-28 Massachusetts Institute Of Technology Method for producing oriented connective tissue cells in a ligament configuration
US5127903A (en) 1990-05-22 1992-07-07 Mailot Kevin G Device for dispensing medicaments to infants
US5281422A (en) 1991-09-24 1994-01-25 Purdue Research Foundation Graft for promoting autogenous tissue growth
US5275826A (en) * 1992-11-13 1994-01-04 Purdue Research Foundation Fluidized intestinal submucosa and its use as an injectable tissue graft
US5641518A (en) 1992-11-13 1997-06-24 Purdue Research Foundation Method of repairing bone tissue
US5352463A (en) 1992-11-13 1994-10-04 Badylak Steven F Tissue graft for surgical reconstruction of a collagenous meniscus and method therefor
US6653291B1 (en) 1992-11-13 2003-11-25 Purdue Research Foundation Composition and method for production of transformed cells
US5902279A (en) 1993-04-20 1999-05-11 Advanced Cytometrix, Inc. Aspiration needle and method
US5942496A (en) 1994-02-18 1999-08-24 The Regent Of The University Of Michigan Methods and compositions for multiple gene transfer into bone cells
US6475232B1 (en) 1996-12-10 2002-11-05 Purdue Research Foundation Stent with reduced thrombogenicity
US5695998A (en) 1995-02-10 1997-12-09 Purdue Research Foundation Submucosa as a growth substrate for islet cells
US5674290A (en) * 1995-04-05 1997-10-07 Li; Shu-Tung Water-stabilized biopolymeric implants
US5554389A (en) 1995-04-07 1996-09-10 Purdue Research Foundation Urinary bladder submucosa derived tissue graft
US5711969A (en) 1995-04-07 1998-01-27 Purdue Research Foundation Large area submucosal tissue graft constructs
DE69622548T2 (en) 1995-04-07 2003-09-18 Purdue Research Foundation West Lafayette TISSUE TRANSPLANT FOR BUBBLE RECONSTRUCTION
ES2208974T3 (en) 1996-08-23 2004-06-16 Cook Biotech, Inc. PROTESIS OF GRAFT, MATERIALS AND METHODS.
CA2273250C (en) 1996-12-10 2008-01-29 Cook Biotech, Inc. Stent grafts containing purified submucosa
CA2267310C (en) 1996-12-10 2012-09-18 Purdue Research Foundation Stomach submucosa derived tissue graft
EP0942739B1 (en) 1996-12-10 2006-04-12 Purdue Research Foundation Biomaterial derived from vertebrate liver tissue
US5814328A (en) * 1997-01-13 1998-09-29 Gunasekaran; Subramanian Preparation of collagen using papain and a reducing agent
US6037144A (en) * 1997-01-29 2000-03-14 Staar Surgical Ag Method of preparing a biological material for use in ophthalmology
DK1011699T3 (en) 1997-09-11 2002-03-11 Purdue Research Foundation Galactosidase-modified submucosal tissue
JP4399585B2 (en) 1998-06-02 2010-01-20 クック インコーポレイティド Multi-sided medical device
DE60041703D1 (en) * 1999-08-06 2009-04-16 Cook Biotech Inc TUBULAR TRANSPLANT CONSTRUCTION
JP4409803B2 (en) 1999-09-10 2010-02-03 クック・インコーポレイテッド Valve assembly for use in a lumen of a vessel and method for making the valve assembly
US6428802B1 (en) * 1999-12-29 2002-08-06 Children's Medical Center Corp. Preparing artificial organs by forming polylayers of different cell populations on a substrate
US6376244B1 (en) 1999-12-29 2002-04-23 Children's Medical Center Corporation Methods and compositions for organ decellularization
PL211860B1 (en) 2000-01-31 2012-07-31 Cook Biotech Inc Valve stent system
CA2397746C (en) 2000-02-03 2010-07-27 Cook Incorporated Implantable vascular device
US6696074B2 (en) * 2000-12-04 2004-02-24 Tei Biosciences, Inc. Processing fetal or neo-natal tissue to produce a scaffold for tissue engineering
US20020182261A1 (en) 2001-05-31 2002-12-05 Jianwu Dai EB matrix production from fetal tissues and its use for tissue repair
AU2002320189B2 (en) 2001-06-28 2007-04-26 Cook Biotech Incorporated Graft prosthesis devices containing renal capsule collagen
EP1659992B1 (en) * 2003-07-31 2013-03-27 Cook Medical Technologies LLC Prosthetic valve devices and methods of making such devices

Also Published As

Publication number Publication date
US20070037283A1 (en) 2007-02-15
EP1404388B1 (en) 2013-10-23
AU2002320189B2 (en) 2007-04-26
EP1404388A1 (en) 2004-04-07
US20030014126A1 (en) 2003-01-16
US7087089B2 (en) 2006-08-08
US7745217B2 (en) 2010-06-29
JP4426285B2 (en) 2010-03-03
CA2452033C (en) 2011-11-08
WO2003002165A1 (en) 2003-01-09
JP2004532714A (en) 2004-10-28

Similar Documents

Publication Publication Date Title
CA2452033A1 (en) Graft prosthesis devices containing renal capsule collagen
Islam et al. Chitosan based bioactive materials in tissue engineering applications-A review
JP6728307B2 (en) Enzyme treatment method for tissue products
Guruswamy Damodaran et al. Tissue and organ decellularization in regenerative medicine
EP2756853B1 (en) Vascular grafts derived from acellular tissue matrices
US20160228235A1 (en) Reinforced Biological Tissue
EP2590691B1 (en) Method for shaping tissue matrices
AU2002320189A1 (en) Graft prosthesis devices containing renal capsule collagen
DE60022197D1 (en) SILVERY BIOGLAS COMPOSITIONS DERIVED FROM SOL-GEL STATES
AU2002310589A1 (en) Decellularisation of matrices
WO2003092471A2 (en) Cell-seeded extracellular matrix grafts
EP0842670A1 (en) Biomedical materials
CN113082295B (en) Derived scaffold based on skin-derived acellular matrix and construction method thereof
Huang et al. In Vitro and In Vivo Characterization of a Silk Fibroin‐Coated Polyester Vascular Prosthesis
KR100739422B1 (en) Calcification-resistant heparinized acellular bioprosthetic tissue implant and preparation method thereof
CN114522249A (en) Preparation method of manganese-containing coating calcium phosphate microspheres and application of manganese-containing coating calcium phosphate microspheres in aspect of drug carrier
CN113908336A (en) Lysozyme phase transition membrane modified cellulose scaffold and preparation method and application thereof
CN112451742A (en) Preparation method of degradable metal-organic matter composite bone repair material
Hassanzadeh Nemati et al. Comparison of SDS and TritonX-100 effects on cell removing of bovine spongy bone for using in bone replacements
KR20010038098A (en) Calcification-resistant Heparinized Bioprosthetic Tissue Implants And Preparation Thereof
RU2796364C1 (en) Method of processing grafts for cardiovascular surgery using sub- and supercritical carbon dioxide
AU2007203460B2 (en) Graft prosthesis devices containing renal capsule collagen
TWI533860B (en) Cell-removed bioilogical structure
Park et al. Novel Modification Method of Bioprosthetic Tissue for Improved Calcification Resistance
PL217290B1 (en) Method for the preparation of biological prostheses, particularly the heart valves

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20220628